Continuing its tradition of launching new prescription products with names unique to Canada, Galderma Canada has announced that the Ivermectin based treatment known as Soolantra in the US will be known as Rosiver in Canada. In Canada, Mirvaso is known as ONRELTEA, and Oracea is known as Apprilon. The full product monograph, including the consumer […]
An interesting finding for those considering Vitamin B12 supplements. A recent study has identified the link responsible in some individuals with taking B12 and developing acne. The study identifies “one molecular explanation for the long-standing clinical observation that vitamin B12 supplementation leads to acne development in a subset of individuals”. Although the link between skin […]
This article details some modest benefits to rosacea symptoms experienced by users of 3% topical tranexamic acid. Trialists of the active topical experienced an improvement in stratum corneum function and in “clinical signs and symptoms of rosacea”. The authors further detail a suggested pathway of how tranexaminc acid benfits rosacea. See the full text link […]
LEFT: Patient at initial clinic visit after 7 months of brimonidine treatment showing compensatory vasodilation and flushing in untreated areas of right lateral cheek and chest. RIGHT: Patient 1 week after cessation of brimonidine treatment showing marked improvement in compensatory vasodilation and flushing. A brief observation published in the Journal of American Medical Association Dermatology […]
Promius Pha rma, a subsidiary of Dr. Reddy’s Laboratory has filed a New Drug Application for a modified release tetracycline for the treatment of rosacea. Promius is calling their new drug DFD-09. Promius Pharma is probably best know to rosacea sufferers via the availability of Promiseb Topical Cream in the US. Promiseb, a treatment for […]
